Furthermore, the tumor-suppressive mechanisms of DRAIC have been reported in glioblastoma [10], gastric adenocarcinoma [11], retinoblastoma [12], and triple-negative/basal subtype of breast carcinoma [13]. This evidence concerns the gene DRAIC and breast carcinoma.